Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
salmeterol xinafoate
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
R03AC12
|
| gptkbp:brand |
gptkb:salmeterol
|
| gptkbp:contraindication |
acute asthma attack
|
| gptkbp:drugClass |
long-acting beta2-adrenergic agonist
|
| gptkbp:form |
inhalation aerosol
inhalation powder |
| https://www.w3.org/2000/01/rdf-schema#label |
Serevent
|
| gptkbp:manufacturer |
GlaxoSmithKline
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:sideEffect |
headache
muscle cramps throat irritation |
| gptkbp:usedFor |
asthma
chronic obstructive pulmonary disease |
| gptkbp:bfsParent |
gptkb:salmeterol
|
| gptkbp:bfsLayer |
8
|